Genes and the cell biology of insulin secretion and insulin resistance

Diabetes Care

Volumn 22, Issue 5, 1999, Pages 849-853

  Bloomgarden, Zachary T ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH FACTOR; INSULIN; NUCLEAR FACTOR;

ATHEROGENESIS; CHROMOSOME 12Q; CHROMOSOME 20Q; CYTOLOGY; DISEASE ASSOCIATION; DNA POLYMORPHISM; GENE EXPRESSION; GENETIC ANALYSIS; HUMAN; INSULIN RELEASE; INSULIN RESISTANCE; MATURITY ONSET DIABETES MELLITUS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PROTEIN EXPRESSION; REVIEW; VASCULAR DISEASE;

DIABETES MELLITUS, TYPE 2; HUMANS; INSULIN; INSULIN RESISTANCE;

EID: 0032896331     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.22.5.849     Document Type: Review

References (13)

1. Fajans SS, Conn JW: Tolbutamide-induced improvement in carbohydrate tolerance of young people with mild diabetes. Diabetes 9:83-88, 1960
2. Bell GI, Xiang KS, Newman MV, Wu SH, Wright LG, Fajans SS, Spielman RS, Cox NJ: Gene for non-insulin-dependent diabetes mellitus (maturity-onset diabetes of the young subtype) is linked to DNA polymorphism on human chromosome 20q. Proc Natl Acad Sci U S A 88:1484-1488, 1991
3. Vaxillaire M, Boccio V, Philippi A, Vigouroux C, Terwilliger J, Passa P, Beckmann JS, Velho G, Lathrop GM, Froguel P: A gene for maturity onset diabetes of the young (MODY) maps to chromosome 12q. Nat Genet 9:418-423, 1995
4. Pontoglio M, Barra J, Hadchouel M, Doyen A, Kress C, Bach JP, Babinet C, Yaniv M: Hepatocyte nuclear factor 1 inactivation results in hepatic dysfunction, phenylketonuria, and renal Fanconi syndrome. Cell 84:575-585, 1996
5. Chen WS, Manova K, Weinstein DC, Duncan SA, Plump AS, Prezioso VR, Bachvarova RF, Darnell JE Jr: Disruption of the HNF-4 gene, expressed in visceral endoderm, leads to cell death in embryonic ectoderm and impaired gastrulation of mouse embryos. Genes Dev 8:2466-2477, 1994
6. Abraira C, Colwell JA, Nuttall FQ, Sawin CT, Nagel NJ, Comstock JR Emanuele NV, Levin SR, Henderson W, Lee HS, VA CSDM Group: Veterans Affairs Cooperative Study on glycemic control and complications in type II diabetes (VA CSDM): Results of the feasibility trial. Diabetes Care 18:1113-1123, 1995
7. Goalstone M, Carel K, Leitner JW, Draznin B: Insulin stimulates the phosphorylation and activity of farnesyltransferase via the Ras-mitogen-activated protein kinase pathway. Endocrinology 138:5119-5124, 1997
8. Levine R, Fritz IB: The relation of insulin to liver metabolism. Diabetes 5:209-219, 1956
9. UK Prospective Diabetes Study (UKPDS). XI: Biochemical risk factors in type 2 diabetic patients at diagnosis compared with age-matched normal subjects. Diabet Med 11:534-544, 1994
10. Haffner SM, Stem MP, Hazuda HP, Mitchell BD, Patterson JK: Cardiovascular risk factors in confirmed prediabetic individuals. Does the clock for coronary heart disease start ticking before the onset of clinical diabetes? JAMA 263:2893-2898, 1990
11. Papademetriou V, Narayan P, Rubins H, Collins D, Robins S: Influence of risk factors on peripheral and cerebrovascular disease in men with coronary artery disease, low high-density lipoprotein cholesterol levels, and desirable low-density lipoprotein cholesterol levels. HIT Investigators. Department of Veterans Affairs HDL Intervention Trial. Am Heart J 136:734-740, 1998
12. Nestler JE, Jakubowicz DJ: Lean women with polycystic ovary syndrome respond to insulin reduction with decreases in ovarian P450c17 alpha activity and serum androgens. J Clin Endocrinol Metab 82:4075-4079, 1997
13. Dunaif A, Scott D, Finegood D, Quintana B, Whitcomb R: The insulin-sensitizing agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovary syndrome. J Clin Endocrinol Metab 81:3299-3306, 1996